Viewing Study NCT05104333


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2025-12-31 @ 10:42 AM
Study NCT ID: NCT05104333
Status: UNKNOWN
Last Update Posted: 2021-11-03
First Post: 2021-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes
Sponsor: China National Biotec Group Company Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module